Clinical medicine profile
Plantago ovata, aloe vera, curcuma longa, garcinia cambogia, commiphora momal, terminalia chebula, piper longum
Traditional / herbal topical & internal (regulated as herbal product)
- Route
- Topical; oral latex (laxative — caution)
- Schedule
- OTC
- ATC
- Not assigned
- PPB status
- registered
Safety essentials
The information most likely to change a prescribing or dispensing decision.
Contraindications
- Hypersensitivity to the active substance or excipients.
- Additional absolute contraindications are indication- and product-specific — consult SmPC.
Precautions
- Do not apply gel to deep/severe burns without clinical care.
- Oral aloe latex may cause cramping, electrolyte loss
- interactions with diuretics/antiarrhythmics possible via K+ loss.
Dosing matrix
Population and organ-function guidance, shown together for faster comparison.
Topical gel: thin layer to intact skin as needed. Oral latex products: avoid routine use; follow labelled herbal product only if registered.
Topical on intact skin only with care; avoid oral latex in children.
Review renal impairment dosing; many agents need CrCl/eGFR adjustment.
- CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Review hepatic impairment dosing; monitor LFTs if agent is hepatically cleared or hepatotoxic.
Use, effects & interactions
Indications
- Traditional and supportive use: minor burns, skin irritation (gel).
- Oral latex historically used as stimulant laxative — not first-line and safety-limited.
- Clinical selection for Plantago ovata, aloe vera, curcuma longa, garcinia cambogia, commiphora momal, terminalia chebula, piper longum should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC.
- Class context: Traditional / herbal topical & internal (regulated as herbal product).
- Confirm site-specific dose, duration and monitoring before prescribing.
Adverse effects
- Adverse reactions vary by agent.
- Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes).
- Report suspected ADRs via national pharmacovigilance channels.
Drug interactions
Open multi-drug checker ↗- Professional use: confirm indication, dose, duration, monitoring and patient counselling points against current Kenya STG / EML and the product SmPC.
- Document allergy status and key interactions.
Mechanism & disposition
A dietary supplement that helps to eliminate body fat, metabolize carbohydrates, and reduce cravings for food Mechanism is agent-specific.
Read complete mechanism
A dietary supplement that helps to eliminate body fat, metabolize carbohydrates, and reduce cravings for food Mechanism is agent-specific. At receptor, enzyme, ion channel, transporter or microbial target level, the drug alters a physiological or pathological pathway to produce its therapeutic effect. Confirm precise molecular mechanism in current SmPC / pharmacology reference for this INN before high-stakes decisions.
Product-specific
Product-specific
Topical; oral latex (laxative — caution)
are product-specific. Consider food effects, protein binding, hepatic CYP/UGT
when adjusting for organ impairment, age and drug interactions. Verify parameters in the current SmPC.
Pregnancy, lactation & diet
Use only if potential benefit justifies potential risk; prefer agents with better reproductive data when alternatives exist.
Assess infant risk vs benefit of maternal therapy; prefer agents with lactation data.
Brands & loaded prices
| Brand | Manufacturer | Pack | Observed price |
|---|---|---|---|
| No reviewed brand listings are linked yet. | |||
Sources & review state
Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.